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Abstract 
All drugs used in aquaculture must be approved by the government agency 
responsible for veterinary medicine; prudent use of antibiotics under 
veterinary supervision is critical in ensuring safety of aquaculture products. 
The international production of farmed turtle, considered a cultured aquatic 
species, has been growing continuously but control of bacteria proliferation in 
turtle farms requires frequent use of antimicrobials. In the present 
investigation, the residue depletion and withdrawal period of quinolone 
antibacterial oxolinic acid (OXO) was evaluated in Chinese softshell turtle 
Pelodiscus sinensis, after repeated (once daily for 5 days) oral doses of 
medicated feed containing OXO, at the dose of 30 and 60 mg/kg body weight 
(bw). Muscle and liver tissues were collected at 1, 2, 4, 8, 12, 16, 20, 24, 28, 
32, 36, 40, 44, and 48 days posttreatment, and OXO was quantified using a 
validated high-performance liquid chromatography with diode array detector 
(HPLC-DAD) method. According to the test preparation record, the limit of 
detection (LOD) and limit of quantification (LOQ) for OXO were estimated at 
0.03 and 0.1 µg/g, respectively. Considering a maximum residue level (MRL) 
of 0.1 µg/g for OXO in muscle in European Union (EU) legislative framework, 
the longest withdrawal period of 72 days was calculated on the basis of a 
safety span (corresponding to 50% of the time point when at which residues 
fall below the MRL) added to the depletion time (48 days). These results may 
be helpful not only for the establishment of public policies regarding the use 
of OXO for turtle farming but also to producers for proper handling to ensure 
safe consumption.  
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Introduction 
The Chinese softshell turtle (Pelodiscus sinensis), an important member of reptilian 
aquaculture with high nutritional and medicinal value, is the best-known species in Asia 
due to its large-scale farming (Rawski et al., 2018). However, literature concerning the 
residual studies in turtle farming is limited, e.g., ticarcillin (Manire et al., 2005), 
florphenicol (Zhu et al., 2006), melamine (He et al., 2012), and meloxicam (Lai et al., 
2015). Similarly, aquatic animal diseases are a major constraint for increasing 
aquaculture production. The water used in aquaculture operations provides an 
environment for growth and proliferation of bacteria which can be influenced by pH, 
temperature, nutrient availability, and other factors that affect their growth pattern, 
virulence, and pathogenicity. Most bacteria responsible for causing disease in aquatic 
animals are gram-negative rods, but some pathogens that are gram-positive rods or 
cocci and a few that are acid-fast rods also cause disease (Ozturk and Altinok, 2014). 
Therapeutic regimes are designed to maximize efficacy and thereby minimize the risk of 
the development of resistant pathogens. 
Oxolinic acid (OXO) is a synthetic antibiotic belonging to the quinolone group, which 
possesses a broad-spectrum antimicrobial agent with bactericidal activity by inhibiting 
the enzyme DNA gyrase (Wolfson et al., 1989). It is available for clinical use, and 
veterinary practice to treat parasitic infections because of these characteristics which 
include high bioavailability, good tissue penetration, long half-lives, high efficacy, and low 
incidence of adverse effects (Bisacchi, 2015; Naeem et al., 2016). OXO is authorized in 
veterinary medicine for use in animals including finfish, calves, pigs, and poultry, etc. For 
pigs and poultry, it was administered at doses of 20 mg/kg bw/day for up to 5 days, 
while in finfish it was given orally at doses of 12 mg/kg bw/day for up to 7 days (EMA, 
2005). The European Medicines Agency (EMA) has set the microbiological acceptable 
daily intakes (ADI) value for OXO at 2.5 µg/kg body weight (i.e., 150 g/person) (EMA, 
2005). To protect consumer health, many countries have defined maximum residue limits 
(MRL) of OXO in animal-derived products (Codex, 2016). The permitted limits the MRLs 
of OXO in muscle and liver tissues of all species are 0.1 and 0.15 µg/g, respectively, 
stated by the European Union (EU) Commission Regulation 37/2010 (EU, 2009).  
The use of OXO in food-producing turtles also has the potential to generate 
residues/food contamination in muscle tissues and poses a health hazard to the 
consumer; proper drug administration and establishing the withdrawal period 
(withholding time) when the animal can be safely slaughtered for food are essential. A 
number of studies have addressed the pharmacokinetics of OXO in fish farming, such as 
rainbow trout (O. mykiss), channel catfish (I. punctatus), orange-spotted grouper (E. 
coioides), Atlantic halibut (H. hippoglossus), corkwing wrasse (S. melops), sea bass (D. 
labrax), gilthead sea bream (S. aurata), sharpsnout sea bream (D. puntazzo), turbot (S. 
maximus), cod (G. morhua), kuruma shrimp (P. japonicus), Atlantic salmon (S. salar) etc. 
Although previous residue reports for OXO have been published (Tyrpenou and Rigos, 
2004; Tu et al., 2006), to our knowledge, no previous work has been conducted in 
freshwater turtles. All prior studies concerning residual control need to define an 
analytical strategy based on confirmatory methods. High performance liquid 
chromatography (HPLC) with fluorescence and UV detection is used for analysis in the 
majority of the methods (Norambuena et al., 2013), while mass spectrometry is used in 
some laboratories (Bladek et al., 2011). 
The purpose of this study was to validate an analytical method and to investigate the 
tissue distribution and residue depletion of OXO in softshell turtle (P. sinensis) in support 
of safe approval for food-producing turtle use in Taiwan. It describes a HPLC method with 
UV detection for OXO residue determination in muscle and liver tissues of cultured 
softshell turtle. These results make it possible to obtain a product compatible with the 
legislative framework, with the intention of protecting consumer health and 
commercialization of this food commodity. 
 
Materials and Methods 
Softshell turtles. 
A total of two hundred healthy turtles (P. sinensis) of both sexes, (weight 450  50 g), 
were used throughout this study. They were obtained from a commercial source and 
were housed in continuous flow-through tap water system until used for experimentation. 
All experimental procedures were approved by the Institution of Animal Care and Use 
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Committee of National Chiayi University. The turtles were acclimatized for two weeks 
during which they were offered raw fish and lettuce ad libitum, and maintained in water 
at a temperature of approximately 22-28°C, salinity of 39.2-39.7, and average pH of 
8.05  0.33, conditions suitable for the maintenance of aquatic species in a closed system 
in a tropical area. 
Reagents. 
HPLC-grade methanol, hexane, and acetonitrile, and reagent-grade oxolinic acid, 
sodium hydroxide, hydrochloric acid, ammonium hydroxide (NH4OH), sodium dihydrogen 
phosphate (NaH2PO4), and disodium hydrogen phosphate (Na2HPO4) were used for 
preparing the solutions or sample treatments. Deionized water was obtained from a Milli-
Q Integral system equipped with a 0.22 µm membrane point-of-use cartridge. 
Preparation of solutions and standards. 
20 mM phosphate buffer solution (PBS) was prepared by dissolving 6.4 g sodium 
dihydrogen phosphate and 21.8 g disodium hydrogen phosphate in 1000 mL of distilled 
water. The pH value was adjusted to 7.4. Stock solution of oxolinic acid (1000 µg/mL) 
was prepared by dissolving 25 mg in 25 mL of methanol and storing in the dark at  
0-4°C. This stock solution was prepared at multilevel working standards with 20 mM PBS 
(pH 7.4) that bracketed the intended sample concentration of 0.025, 0.05, 0.1, 0.25, 
0.5, 1, 2.5, 5 and 10 µg/mL. 
Pharmacokinetic study. 
Animals (n = 6/group) were randomized divided into treatment groups. They were 
given OXO in capsule form with a meal once daily for five days to define the optimal dose 
and dosing interval for the field trial. The low dose of 30 mg/kg/day was selected based 
on empirical, positive impressions of clinical efficacy in other aquatic species (Endo et al., 
1973; Rigos et al., 2003). The high dose of 60 mg/kg/day was chosen to monitor safety 
at the 2 dose levels in multiple-dose study. Six turtles were taken at the following time 
points: 1, 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, and 48 days after the last dose for 
the determination of tissue OXO concentrations. Following completion of muscle and liver 
sampling, samples were kept frozen at -20°C until analyzed. Animals in the control set 
(no OXO added) were processed simultaneously. 
Extraction & cleanup process. 
Extraction and cleanup which was performed after a previous extraction included the 
following steps. When muscle or liver samples were thawed and homogenized, sample 
homogenate (3.0 g) was weighed in a 15-mL polypropylene centrifuge tube, and 50 mM 
PBS at pH 7.4 (5 mL) was added. The mixture was then placed in an ultrasonic bath (10 
min) and centrifuged (4,000 xg, 10 min). The supernatant was then transferred into a 
clean tube. The extraction procedure was performed twice, and the two extracts were 
combined. Hexane (2 mL) was added to the extract sample and the mixture was 
thoroughly shaken in a vertical shaker for 10 min. Samples were centrifuged (4,000 xg, 
10min), then the upper hexane layer was discarded. The remaining extract in the water 
layer was collected and saved for later use. 
A 3-mL (500 mg) C-18 solid-phase extraction cartridge (Sep-Pak C18) was activated 
with 3 mL of methanol followed by 3 mL of deionized water at the rate of 1 mL/min. Care 
was taken to prevent air from reaching the stationary phase in this step. After this 
muscle or liver sample extraction was loaded onto the column and disposed of. The 
column was subsequently washed with 3 mL of deionized water at a rate of 1 mL/min. 
Elution was then carried out with 5 mL of a mixture of methanol and 30% ammonium 
hydroxide (74: 26 v/v) at 1 mL/min and decanted into a 10-mL Quickfit glass tube. The 
extract was evaporated under a gentle stream of nitrogen at 40°C. The dry residue was 
dissolved as described above in 50 mM PBS (pH 7.4, 1 mL) and filtered through a PVDF 
Millex filter (0.45 µm, 13 mm). Finally, 20 μL was injected into the HPLC system for OXO 
analysis under the optimized analytical conditions. 
Chromatography analysis. 
Samples were analyzed in diode array detection HPLC following the analytic method 
of Tu et al. (2006), with minor modification. Analytes were separated using a C18 
reversed-phase column (150  4.6 mm ID, 5 µm Cosmosil 5C18-MS-II). The waters HPLC 
system consisted of 600E multi-solvent delivery system, a 717 auto sampler, and a 996 
photodiode array detector set from 210 to 300 nm to scan the adsorption spectrum of 
OXO. The injection volume was 20 µL, while the mobile phase consisted of 
acetonitrile:water (50:50, v/v), an isocratic elution was used at a flow rate of 0.5 
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mL/min. 
HPLC methods were validated prior to assay. The intra-day and inter-day precision as 
well as accuracy of the method were assessed by spiking OXO at three concentrations of 
0.1, 1, and 10 µg/mL. A triplicate determination of each concentration was conducted 
during routine operation of the system over a period of three consecutive days. The 
recovery test was preceded in triplicate by spiking blank tissue homogenates (muscle and 
liver) with known concentrations (0.1, 1 and 10 µg/g) of OXO. Data acquisition was 
performed using Millennium 32 software (Version 4.0, Waters). 
 
Results 
Methods validation  
The following validation parameters were achieved: linearity (r) higher than 0.997 in the 
range from 0.025 to 10 µg/mL, the intra and inter-day precision (CV%) were lower than 
5.2 and 4.2%, respectively. Under the conditions mentioned above, the examined OXO 
was well resolved and was achieved in less than 8 min. Analyte detection and 
quantification was realized at 260 nm. The method showed satisfactory recoveries (75 to 
88%) for all concentrations studied. The limit of detection (LOD) was estimated at 0.03 
µg/g (average blank signal + 3 standard deviations of the blank signal), and the limit of 
quantification (LOQ) was estimated at 0.10 µg/g (average blank signal + 10 standard 
deviations of the blank signal). No effect of the co-extracted biological material was 
detected. 
 Residue depletion studies  
 The multiple-dose treatment in the residue study was measurable for up to 48 days. 
After consecutive 5-day oral dosing at 30 or 60 mg/kg/day, OXO residue concentrations 
for the high-dose group increased proportionally, calculated as twice that obtained for 
the group dosed at 30 mg/kg. The results of the OXO depletion are shown in Table 1, 
indicating that there was accumulation of OXO when given at 30 or 60 mg/kg for 5-day 
and that OXO is slowly eliminated after the discontinuation of the treatment. These data 
indicated that the concentrations of OXO in the tissues were the highest at day one and 
declined in the following days to near-undetectable levels: range 0.06 − 0.10 μg/g in the 
muscle (at day 44), and 0.05 − 0.10 μg/g in liver (at day 48), respectively, for animals in 
the high-dose groups, which were below the MRL values for muscles at 0.1 µg/g by the 
European Community (EU, 2009). The highest residue concentrations occurred in the 
liver at all times. 
Table 1. Concentrations (Mean  SD) of oxolinic acid (g/g) in Chinese softshell turtle (Pelodiscus sinensis) 
tissues following multiple dosing (5 days) of medicated diet (30 & 60 mg/kg turtle, n = 6/group) at 22-28°C. 
  Low dose (30 mg/kg/day)  High dose (60 mg/kg/day) 
1Days  Control Muscle Liver  Control Muscle Liver 
1  2UDL 0.15 01 3. 0.27 3.55   UDL 0.58 5.71  0.72 5.21  
2  UDL 0.28 2.66  0.25 2.86   UDL 0.59 4.75  0.65 4.23  
4  UDL 0.26 2.29  0.44 2.24   UDL 0.31 3.46  0.44 3.08  
8  UDL 0.12 2.20  0.39 1.31   UDL 0.13 2.24  0.15 1.79  
12  UDL 0.09 1.03  0.16 0.78   UDL 0.09 1.92  0.05 1.17  
16  UDL 0.11 0.61  0.09 0.56   UDL 0.11 1.53  0.03 1.05  
20  UDL 0.06 0.21  0.09 0.32   LUD 0.07 0.62  0.08 0.80  
24  UDL 0.03 0.14  0.04 0.24   UDL 0.07 0.46  0.08 0.45  
28  UDL 0.13  0.03 .030 0.16   UDL 0.08 0.34  0.04 0.27  
32  UDL 0.09  0.03 0.03 0.10   UDL 0.04 0.23  0.05 0.23  
36  UDL 0.07  0.02 0.02 0.07   UDL 0.03 0.17  0.04 0.20  
40  UDL 0.06  0.01 0.01 0.06   UDL 0.03 0.10  0.04 0.16  
44  UDL UDL 0.01 0.05   UDL 0.02 0.09  0.03 0.11  
48  UDL UDL UDL  UDL 0.02 0.06  0.02 0.07  
1 Day 1 is the first day after the final dose. 
2 UDL = Under detection limit. 
Discussion 
Literature records concerning the pharmacokinetics of OXO in turtle are currently limited. 
Previous studies have reported that OXO had a minimum inhibiting concentration (MIC) 
that ranged between 3.8 to 5.6 μg/mL. This concentration can inhibit the growth of 
major pathogenic bacteria (e.g., V. alginolyticus, V. harveyi, V. campbellii, V. 
parahaemolyticus and A. hydrophila) in seawater and freshwater (Li et al., 2001). A 
toxicological examination of OXO was performed at overdoses (1600 mg/kg) fifty times 
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the standard dose in softshell turtle (250 g), and surviving animals showed no clinical 
signs of obvious toxicity 48 hours post-administration (Li et al., 2001). 
There have been no reports on residue depletion of OXO in softshell turtle to date. In 
comparison to other aquatic species testing, a single-dose pharmacokinetics of OXO in 
orange-spotted grouper (Epinephelus coioides) revealed that the elimination half-life was 
15.1 hours in the serum, at an administation dosage 40 mg/kg at 24  2 °C (fish were 
sampled at 3, 6, 9, 12, 24, 48, 72, 96, 168, 240 and 336 hours after administration), 
and the residues dropped below the MRL approximately after 10 days following 
medication (Guo and Liao, 1994). 
In the case of OXO, multiple medications, 30 mg/kg/day for 10 days treatment at 19 
 1°C in seawater it was found the accumulation of drugs following multiple dosing is 
directly proportional to the elimination half-life (t1/2) in association with the dosing 
interval (Rigos et al. 2003). The calculated t1/2 of OXO were estimated to be 11-14 and 
11-19 hours in several tissues, including plasma, muscle, liver, and skin of gilthead 
seabream and sharpsnout seabream, respectively. The above data revealed that the 
concentrations of OXO against in the edible tissues were below the MRL at day-11 (24 h 
post-multiple 10-day dosing), thus, the fast elimination and rapid depletion of OXO 
suggests short withdrawal times (within 24 h of cessation of treatments) with reference 
to human consumption of treated sparids (Rigos et al., 2003). The reason for the 
apparent discrepancies between in vivo depletion studies is unclear; however, it may 
relate to differences in species; more work is needed to clarify this issue. 
Although there was no information concerning the further metabolism of OXO in 
sparids, previous rainbow trout and yellowtail studies have demonstrated that 
glucuronide (OXO-G) was found to be the major metabolite of OXO. Glucuronidation is 
therefore thought to be the most important stage of the metabolic pathway for OXO in 
fish (Ishida, 1992; Ueno et al., 1998). 
In addition, the elimination rates of antibiotics also depend on several environmental 
factors such as light, salinity, or seawater temperature. A previous study on the depletion 
of veterinary drugs in gilthead seabream under experimental field conditions at 14 and 
19°C (Gonzalez et al., 2010) showed that microbial degradation contributes more to the 
disappearance of OXO than do environmental factors such as temperature. Additionally, 
OXO was eliminated much faster in rainbow trout kept in seawater than those in 
freshwater (Ishida, 1992), the cause of salinity plays an important role in xenobiotic 
metabolism and excretion. 
On the whole, this is the first residual study of OXO in softshell turtle, the final 
withdrawal period has to be set in a way that the residues in all target tissues drop below 
their specific MRLs, and, in addition, that the amount of residues in the edible portion 
drops below the ADI (2.5 µg/kg bw/day) (EMA, 2018). This means that the longest 
withdrawal period must be selected to be in full compliance with the MRLs and the ADI. 
Therefore, to account for the high variability of the residue data, a safety span must be 
added to the depletion time of 48 days. A safety span corresponding to 50% of the 48-
day depletion time can be seen as appropriate. Thus, the conclusive approach would then 
result in a withdrawal period of 72 days in the present study. 
The present study provides preliminary data supporting more prudent use of OXO for 
turtle farming and suggests a possible withdrawal time after treatment. The long 
clearance of OXO from edible tissues may correlate with their slow metabolism (Martin 
and Palumbi, 1993), but excretion mechanisms remain unclear. 
In conclusion, our study is the first to report OXO depletion in freshwater softshell 
turtle. The potential health risk of turtle dishes to humans, as a consequence of OXO 
residues derived from turtles treated with medicated feed, in the doses used in this study 
(30 & 60 mg/kg bw for 5-day), can be considered safe for consumption if a withdrawal 
period of 72 days is observed. The findings suggest that turtles metabolize OXO much 
more slowly than other aquatic animals studied. The depletion behavior we have detailed 
in this work could therefore aid in the design and application of new policies of 
antimicrobial surveillance. 
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